Jobs at Scholar Rock (Now Hiring) — 6 open
Senior Associate Scientist I, Bioanalytical Assay Development
Cambridge, Massachusetts, United States · On-site
$80k–$100k/yr
Mid level$743M raised
Scholar Rock is a late-stage global biopharmaceutical company focused on developing and commercializing apitegromab for children and adults with spinal muscular atrophy (SMA) and other rare, severe, and debilitating neur…
Skills: Bioanalytical Assay Development, Pharmacokinetic Assays, Immunogenicity Assays, Biomarker Assays, ELISA
Vice President, Commercial Legal Counsel
Cambridge, Massachusetts, United States · Hybrid
$325k–$400k/yr
Senior+$743M raised
Scholar Rock is a late-stage global biopharmaceutical company focused on developing and commercializing apitegromab for children and adults with spinal muscular atrophy (SMA) and other rare, severe, and debilitating neur…
Skills: Commercial Legal Counsel, Healthcare Compliance, FDA Advertising and Promotion, Rare Disease Product Launch, Commercial Contracting
Associate Director, Clinical Operations Compliance
Cambridge, Massachusetts, United States · Hybrid
$175k–$225k/yr
Senior+$743M raised
Scholar Rock is a late-stage global biopharmaceutical company focused on developing and commercializing apitegromab for children and adults with spinal muscular atrophy (SMA) and other rare, severe, and debilitating neur…
Skills: Clinical Operations Compliance, TMF Standards, SOP Development, GCP, ICH Guidelines
Director, Supply Chain Japan
Tokyo, Japan · Remote OK
Senior+$743M raised
Scholar Rock is a late-stage global biopharmaceutical company focused on developing and commercializing apitegromab for children and adults with spinal muscular atrophy (SMA) and other rare, severe, and debilitating neur…
Skills: Supply Chain Management, Commercial Product Launch, External Partner Management, Strategic Planning, Budgeting
Sr. Director, Commercial Quality / Market Quality
On-site
Senior+$743M raised
Scholar Rock is a late-stage global biopharmaceutical company focused on developing and commercializing apitegromab for children and adults with spinal muscular atrophy (SMA) and other rare, severe, and debilitating neur…
Skills: Commercial Quality, Market Release Authorization, QP Certification, GDP Compliance, Post-Market Quality Systems
Director, Program Management, Next Wave
Cambridge, Massachusetts, United States · On-site
$215k–$250k/yr
Senior+$743M raised
Scholar Rock is a late-stage global biopharmaceutical company focused on developing and commercializing apitegromab for children and adults with spinal muscular atrophy (SMA) and other rare, severe, and debilitating neur…
Skills: Program Management, Clinical Development, Risk Mitigation, Scenario Planning, Cross-functional Leadership